Quantcast

Latest epinephrine Stories

2014-08-25 08:24:15

Video Will Aim to Address Gaps in Knowledge About Life-Threatening (Severe) Allergies PITTSBURGH, Aug. 25, 2014 /PRNewswire/ -- Mylan Specialty, the fully integrated specialty pharmaceutical business of Mylan Inc. (NASDAQ: MYL), and pro football player and EpiPen(®) (epinephrine) Auto-Injector spokesperson Adrian Peterson today announced the three winners of the Ready2Go(TM) MVP Draft, a nationwide search to find kids who have potentially life-threatening (severe) allergies and are prepared...

2014-06-02 08:26:04

Peterson Calls on Kids with Potentially Life-threatening (Severe) Allergies to Join His Ready2Go MVP Team PITTSBURGH, June 2, 2014 /PRNewswire/ -- Mylan Specialty, the fully integrated specialty pharmaceutical business of Mylan Inc. (NASDAQ: MYL), and pro football player Adrian Peterson today launched Ready2Go(TM), a new campaign to educate those affected by severe allergies about what to do if a life-threatening allergic reaction, or anaphylaxis, happens. Ready2Go was inspired in part by a...

2014-05-13 08:27:48

- What's Your AQ? Answers Common Anaphylaxis Questions During National Asthma and Allergy Awareness Month - BRIDGEWATER, N.J., May 13, 2014 /PRNewswire/ -- Professional football icon Jerome Bettis, the Asthma and Allergy Foundation of America (AAFA) and Sanofi US, the makers of Auvi-Q(®) (epinephrine injection, USP), are asking What's Your AQ? in an effort to help improve America's understanding of severe, life-threatening allergic reactions (anaphylaxis) and to help clear up some...

2014-05-01 16:33:47

Direct Relief to distribute product across America to nonprofit health centers, clinics, and allergy camps SANTA BARBARA, Calif., May 1, 2014 /PRNewswire-USNewswire/ -- The Sanofi Foundation for North America has donated more than 90,000 Auvi-Q(®) (epinephrine injection, USP) epinephrine auto-injectors to medical aid organization Direct Relief for distribution to nonprofit health centers, clinics, and allergy camps across the U.S. that care for people at risk of life-threatening...

2014-04-28 23:00:32

UC Davis finding may lead to novel stem cell treatments for chronic wounds. Sacramento, CA (PRWEB) April 28, 2014 The stress hormone epinephrine — the source of the “fight-or-flight” response — also heightens stresses at the cellular level, inhibiting wound healing and promoting a state of chronic inflammation that prohibits the body’s stem cells from migrating to a wound to encourage skin regeneration, UC Davis researchers have found. The research, published in the April issue...

2014-04-11 12:24:06

DUBLIN, Ireland, April 11, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/53hl65/global) has announced the addition of the "Global Epinephrine Auto-Injector Market Report" [http://www.researchandmarkets.com/research/53hl65/global ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) The analysts forecast the Global Epinephrine Auto-injector market to grow at a CAGR of 13.34 percent over the...

2014-03-01 12:20:28

Two poster presentations will highlight initial findings from The Anaphylaxis Risk Assessment (TARA) study, one of the largest U.S. managed care retrospective database reviews to date PITTSBURGH, March 1, 2014 /PRNewswire/ -- Mylan Specialty will present initial data from The Anaphylaxis Risk Assessment (TARA) study at the 2014 Annual Meeting of the American Academy of Allergy, Asthma and Immunology (AAAAI) held in San Diego, Calif., Feb. 28 - March 4. TARA aims to uncover factors associated...

2014-02-19 16:25:14

VIENNA, Va., Feb. 19, 2014 /PRNewswire-USNewswire/ -- An over-the-counter (OTC) asthma inhaler up for approval by the U.S. Food & Drug Administration (FDA) endangers patients by encouraging substandard treatment, according to Allergy & Asthma Network Mothers of Asthmatics (AANMA), a leading nonprofit patient education and advocacy organization. On Feb. 25, FDA's Nonprescription Drugs Advisory Committee and Pulmonary Allergy Drugs Committee will host a joint meeting to consider a new...

2014-02-07 16:24:13

TORONTO, Feb. 7, 2014 /CNW/ - Pfizer Canada Inc., the Canadian distributor of EpiPen® (epinephrine) Auto Injector is proud to announce its entry in the 2014 NASCAR Canadian Tire Series as the title sponsor of Alex Tagliani's No. 18 car. "Pfizer is pleased to be entering the NASCAR Canadian Tire Series as Alex Tagliani's title sponsor," said Allen Van Der Wee, General Manager, Global Established Products Business Unit at Pfizer Canada Inc. "We are looking forward to partnering...

2014-01-06 12:28:29

RICHMOND, Va., Jan. 6, 2014 /PRNewswire/ -- Intelliject, Inc. a pharmaceutical company based in Richmond, VA has announced that its company name has been changed to kaleo, Inc. In normal usage, the company will be known as kaleo. Announcing the change, Spencer Williamson, President and CEO of kaleo said, "We are excited that our new name, kaleo, will help to communicate our future as a leader in developing a new generation of personal lifesaving medical products." "The name kaleo is...


Word of the Day
jument
  • A beast of burden; also, a beast in general.
'Jument' ultimately comes from the Latin 'jugum,' yoke.
Related